Dear all,we invite you to the inaugural A4ID Annual Conference 2021, held on 25-26 June 2021via Zoom. This year’s theme: ‘Towards a more just post-pandemic world will focus on ideas that are emerging as responses from the rule of law and pro bono space to address the challenges of the ongoing pandemic.’ As an organization closely ...
World Health Organization (WHO) estimates from 2017 indicates that 10.5% of medical products available in low- and middle-income countries (LMICs) are “substandard or falsified” (SF). Substandard health products are approved by the national regulators, but they do not comply with adequate standards due to undetected errors, negligence, or poor practice in manufacturing, transportation, or storage. ...
#TeamEuropeQUAMED was honoured to participate in a high-level round table hosted by Enabel, and in presence of Minister Kitir on May 6. Participants spanning the Belgian life sciences, academic research and development-cooperation ecosystem contemplated potential contributions and added value that Belgium can bring to scaling up the production capacity of vaccines, medicines and medical products ...
This week QUAMED is organising a webinar on biological medicines. What are they, how are they made, how are they regulated and what about access to biological medicines in LMIC settings. The webinar is presented by Thomas Chattaway and it is given in English and in French. Accessible for all our members.
Be-cause Health & QUAMED literature updates Ref. Twesigye G, Hafner T, Guzman J. Making the investment case for national regulatory authorities. J Pharm Pol Practices 2021: 14-16; https://doi.org/10.1186/s40545-021-00299-7 Dear Friend, In the attached paper, Twesigye and colleagues make an important case that there is a need to support the strengthening of national regulatory authorities (NRAs), which play an ...
A few of our stakeholders work with or have worked with The Global Pharma Health Fund (GPHF) Minilab. Read more about how GPHF has released the COVID-19 Special Manual Issue containing two test methods for its Minilab testing platform. https://www.gphf.org/newsletter/data/nl_2021-03-04_en.htm
Following the multi-stakeholder Call to AU Heads of State to Ratify the AMA Treaty the IAPO will be holding a virtual panel discussion on “Why an African Medicines Agency, Why Now?” that will take place from 14.20 to 15.20 CET on Wednesday, March 10th, as part of the African Health Agenda International Conference (AHAIC) 2021. The panel ...
QUAMED’s experts have completed a Good Storage and Distribution Practices audit at CAMESKIN ( https://www.cameskin.org/ ) and GSDP technical visits with two private-sector for-profit pharmaceutical wholesalers. They are still in Kinshasa. The picture shows our experts in the CAMESKIN warehouse. Friday one of our experts will be travelling to Goma and visit Asrames (www.asrames.org) and the ...
Be-cause Health & QUAMED literature updates References: Faiva et al. Drug supply shortage in Nigeria during COVID‑19: efforts and challenges J of Pharm Policy and Pract (2021) 14:17 Uwizeyimana et al. Drug supply situation in Rwanda during COVID‑19: issues, efforts and challenges J of Pharm Policy and Pract (2021) 14:12 Dear Friend, Proper supply of ...
QUAMED fully supports the call to the Heads of State of the African Union to Ratify the African Medicines Agency Treaty. See for more information: https://lnkd.in/daiTKth.
Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.
En poursuivant votre visite sur ce site, vous acceptez l'utilisation de cookies En savoir plus
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.